We are live on ! Find out more
FCMV

Foresite Capital Management V Portfolio holdings

AUM $271M
1-Year Est. Return 309.87%
This Fund
S&P 500
This Quarter Est. Return
-16.14%
1 Year Est. Return
+309.87%
3 Year Est. Return
+356.88%
5 Year Est. Return
+250.56%
10 Year Est. Return
–
AUM
$87.6M
AUM Growth
-$32.6M
Cap. Flow
-$23.9M
Cap. Flow %
-27.32%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
CGON icon
CG Oncology
CGON
+$4.68M
2
MAZE
Maze Therapeutics
MAZE
+$4.16M

Top Sells

Rank Stock Value
1
HIMS icon
Hims & Hers Health
HIMS
+$24.8M
2
CGEM icon
Cullinan Oncology
CGEM
+$8.01M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALMS
1
Alumis Inc
ALMS
$3.57B
$35.5M 40.5%
5,779,348
– –
CGON icon
2
CG Oncology
CGON
$6.11B
$21M 24.01%
859,050
+166,500
+24% +$4.68M
IRON icon
3
Disc Medicine
IRON
$2.83B
$14.8M 16.94%
299,069
– –
HIMS icon
4
Hims & Hers Health
HIMS
$6.5B
$8.07M 9.21%
273,151
-666,709
-71% -$24.8M
LYEL icon
5
Lyell Immunopharma
LYEL
$309M
$4.38M 4.99%
406,652
– –
MAZE
6
Maze Therapeutics
MAZE
$1.53B
$3.8M 4.34%
+345,191
New +$4.16M
CGEM icon
7
Cullinan Oncology
CGEM
$1.05B
– –
-657,905
Closed -$8.01M

Similar funds

MAM
Mullooly Asset Management Wall Township, New Jersey $271M AUM 16.93% 1-Year Est. Return
MLM
Mount Lucas Management Newtown, Pennsylvania $271M AUM 25.49% 1-Year Est. Return
PFG
Prosperity Financial Group San Ramon, California $271M AUM 30.27% 1-Year Est. Return
MCM
Moerus Capital Management New York $271M AUM 58.78% 1-Year Est. Return
RP
Ravenswood Partners Mclean, Virginia $271M AUM
PCM
Punch Card Management Winter Park, Florida $271M AUM 11.49% 1-Year Est. Return
ACH
Axis Capital Holdings Pembroke, Bermuda $270M AUM 16.26% 1-Year Est. Return
S
Siemens Munich, Germany $272M AUM 183.71% 1-Year Est. Return

Foresite Capital Management V's Q1 2025 Portfolio in Review

As of Q1 2025, Foresite Capital Management V held 7 positions worth $87.6M, down 27% from $120M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management V withdrew a net $23.9M in Q1 2025, closing 1 position and reducing 1 holding. Its most notable exit was Cullinan Oncology, an estimated $8.01M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Foresite Capital Management V opened a new position in Maze Therapeutics worth $3.8M.

  • Foresite Capital Management V's largest Q1 2025 buy was Maze Therapeutics: 345,191 shares worth $3.8M.
  • Foresite Capital Management V added most to CG Oncology in Q1 2025, an estimated $4.68M increase.
  • Foresite Capital Management V's biggest Q1 2025 reduction was Hims & Hers Health, cutting an estimated $24.8M.
  • Foresite Capital Management V fully exited Cullinan Oncology in Q1 2025, selling an estimated $8.01M.
  • Foresite Capital Management V's ten largest holdings make up 100% of its $87.6M portfolio in Q1 2025.
  • Foresite Capital Management V opened 1 new position and closed 1 in Q1 2025.
  • Foresite Capital Management V's portfolio value fell 27% quarter-over-quarter to $87.6M.

Based on Foresite Capital Management V's 13F filing for Q1 2025, filed 15 May 2025.